Product Details
Place of Origin: China
Brand Name: Quickoolchem
Payment & Shipping Terms
Minimum Order Quantity: 50 Grams
Price: Negotiable
Packaging Details: bulk powder, 15mg/tube or customized
Delivery Time: 1-3 working day
Payment Terms: L/C, L/C, D/A, D/P, T/T, Western Union, MoneyGram
Supply Ability: 10 MT/Month
Type: |
Pharmaceutical Intermediates |
Assay: |
>99% |
Service: |
Professional & Rich Experience |
Shelf Life: |
2 Years |
Specification: |
1kg/bag 25kg/drum |
Solubility: |
Soluble In Water |
COA: |
Available |
Appearance: |
White To Off-white Powder |
Shipping Method: |
Air(UPS, FedEx, TNT, EMS) Or Sea |
Storage: |
Store In A Cool, Dry Place |
Origin: |
China |
CAS: |
2023788-19-2 |
Type: |
Pharmaceutical Intermediates |
Assay: |
>99% |
Service: |
Professional & Rich Experience |
Shelf Life: |
2 Years |
Specification: |
1kg/bag 25kg/drum |
Solubility: |
Soluble In Water |
COA: |
Available |
Appearance: |
White To Off-white Powder |
Shipping Method: |
Air(UPS, FedEx, TNT, EMS) Or Sea |
Storage: |
Store In A Cool, Dry Place |
Origin: |
China |
CAS: |
2023788-19-2 |
Tirzepatide powder is the raw form of Tirzepatide, a groundbreaking synthetic peptide used primarily for managing type 2 diabetes. This compound is a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, which play a critical role in glucose metabolism. By activating both receptors, Tirzepatide enhances insulin secretion in response to elevated blood glucose levels, suppresses the release of glucagon (a hormone that raises blood sugar), and slows gastric emptying. These actions contribute to more effective blood sugar control, especially after meals, which is vital for individuals with type 2 diabetes.
In addition to its glucose-lowering effects, Tirzepatide has demonstrated significant potential for promoting weight loss, making it a valuable option for patients struggling with obesity and diabetes. The powder form of Tirzepatide is primarily utilized in pharmaceutical manufacturing and research settings, where it undergoes further processing into injectable formulations for clinical use. As a result, it requires careful handling and precise formulation to ensure safety and efficacy.
Tirzepatide is typically administered through subcutaneous injections, with dosages gradually titrated to optimize patient outcomes while minimizing side effects. Its innovative mechanism of action sets it apart from traditional diabetes medications, providing an exciting new avenue for diabetes management. As ongoing research continues to explore the full range of Tirzepatide's effects and potential applications, it represents a significant advancement in the treatment landscape for type 2 diabetes and related metabolic disorders.
Products Name: |
Tirzepatide
|
CAS No.: | 2023788-19-2 |
Purity: | ≥99.5% |
Appearance: | White Lyophilized powder |
Logo printing: | Available |
Storage: | Cool Dry Place |
The dosage of Tirzepatide for treating type 2 diabetes, typically follows a gradual titration to minimize side effects and optimize effectiveness. It is administered via subcutaneous injection once weekly.
Here’s a general dosing schedule:
1. Starting dose: 2.5 mg once a week for the first 4 weeks. This low dose helps the body adjust to the medication.
2. Dose escalation:
After 4 weeks at 2.5 mg, the dose is increased to 5 mg once weekly.
If further blood sugar control is needed, the dose may be increased in 2.5 mg increments every 4 weeks, up to a maximum dose of 15 mg per week.
Titration schedule:
Week 1–4: 2.5 mg weekly
Week 5–8: 5 mg weekly
After 8 weeks: Based on effectiveness and tolerance, the dose may be increased to 7.5 mg, 10 mg, 12.5 mg, or 15 mg.
The dosage is tailored to the individual patient’s needs and response to the medication. Higher doses may offer additional benefits for glucose control and weight loss, but they also increase the likelihood of gastrointestinal side effects, such as nausea or diarrhea.
Patients should follow the dosage prescribed by their healthcare provider to ensure safety and efficacy.
1. Dual Receptor Agonism:
Tirzepatide acts as a dual agonist for the GLP-1 (glucagon-like peptide-1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor. This unique mechanism enhances its efficacy in managing blood sugar levels.
2. Enhanced Insulin Secretion:
By stimulating the GLP-1 and GIP receptors, Tirzepatide increases insulin secretion from the pancreas in response to elevated blood glucose levels. This helps to lower blood sugar levels, especially after meals.
3. Reduced Glucagon Levels:
Tirzepatide suppresses the secretion of glucagon, a hormone that increases blood sugar levels. By lowering glucagon levels, it helps to prevent hyperglycemia (high blood sugar).
4. Slowed Gastric Emptying:
The medication delays gastric emptying, which leads to a more gradual absorption of glucose into the bloodstream. This results in improved postprandial (after meal) blood sugar control and enhanced satiety.
5. Weight Loss:
Tirzepatide promotes significant weight loss by reducing appetite and increasing feelings of fullness. This is particularly beneficial for individuals with type 2 diabetes who may be overweight or obese, as weight management is crucial for improving metabolic health.